The cost of medication to treat multiple sclerosis has risen much faster than inflation, even for older drugs. Patients and insurers say manufacturers’ subsidy programs have helped, but not enough.
The cost of medication to treat multiple sclerosis has risen much faster than inflation, even for older drugs. Patients and insurers say manufacturers’ subsidy programs have helped, but not enough.